Pages that link to "Q39753161"
Jump to navigation
Jump to search
The following pages link to Effects of prostratin on T-cell activation and human immunodeficiency virus latency (Q39753161):
Displaying 50 items.
- Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells (Q24548940) (← links)
- Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue (Q24562082) (← links)
- Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells (Q24644201) (← links)
- Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV (Q24654112) (← links)
- Latency: the hidden HIV-1 challenge (Q25255905) (← links)
- Targeting the latent reservoir to achieve functional HIV cure (Q26745923) (← links)
- Animal Models for HIV Cure Research (Q26767476) (← links)
- Redefining the viral reservoirs that prevent HIV-1 eradication (Q26827255) (← links)
- Studies of retroviral infection in humanized mice (Q26849806) (← links)
- Developing Combined HIV Vaccine Strategies for a Functional Cure (Q26998898) (← links)
- Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency (Q27026631) (← links)
- Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers (Q27312050) (← links)
- Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research (Q28077662) (← links)
- Epigenetic regulation of HIV-1 latency by cytosine methylation (Q28475636) (← links)
- Activation of latent HIV using drug-loaded nanoparticles (Q28477657) (← links)
- An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression (Q28546918) (← links)
- Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1 (Q28655602) (← links)
- Bioinformatics opportunities for identification and study of medicinal plants (Q28709643) (← links)
- Directly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latency (Q28728736) (← links)
- Therapy for persistent HIV. (Q30386370) (← links)
- Nature's medicines: traditional knowledge and intellectual property management. Case studies from the National Institutes of Health (NIH), USA (Q30397272) (← links)
- Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro (Q30558754) (← links)
- Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells (Q33250088) (← links)
- Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection (Q33476165) (← links)
- Combinatorial latency reactivation for HIV-1 subtypes and variants (Q33877492) (← links)
- Protein kinase D3 is essential for prostratin-activated transcription of integrated HIV-1 provirus promoter via NF-κB signaling pathway (Q34022422) (← links)
- Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation (Q34096946) (← links)
- A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs (Q34145909) (← links)
- Rational design of drugs that induce human immunodeficiency virus replication (Q34229958) (← links)
- Molecular Characterization, Reactivation, and Depletion of Latent HIV (Q34263657) (← links)
- Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB (Q34482017) (← links)
- Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies (Q34607763) (← links)
- Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay (Q34758220) (← links)
- Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy (Q34857454) (← links)
- Latency in human immunodeficiency virus type 1 infection: no easy answers (Q35044157) (← links)
- High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor. (Q35065109) (← links)
- Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations. (Q35720063) (← links)
- Apoptosis-induced activation of HIV-1 in latently infected cell lines (Q35747595) (← links)
- High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms (Q35784937) (← links)
- Protein Kinase C: One Pathway towards the Eradication of Latent HIV-1 Reservoirs (Q35830264) (← links)
- Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells (Q35833324) (← links)
- Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors. (Q35942658) (← links)
- The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention (Q36001865) (← links)
- Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients (Q36076018) (← links)
- Latent HIV-1 infection occurs in multiple subsets of hematopoietic progenitor cells and is reversed by NF-κB activation. (Q36155046) (← links)
- Euphorbia Kansui Reactivates Latent HIV. (Q36224979) (← links)
- Molecular mechanisms of HIV-1 proviral latency (Q36278085) (← links)
- Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication (Q36330062) (← links)
- Molecular mechanisms of HIV latency (Q36515063) (← links)
- In vivo platforms for analysis of HIV persistence and eradication (Q36515119) (← links)